Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Kirk K. Calhoun
AddedMar 31, 2024
UpdatedMay 1, 2026
Kirk K. Calhoun

Kirk K. Calhoun

Board Member, NantHealth

Kirk K. Calhoun's Career

NantHealth
NantHealth

Culver City, CA, US

Board Member· Board
Ryerson Holding
Ryerson Holding

Chicago, IL, US

Board Member· Board
NeuroSigma
NeuroSigma

Los Angeles, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Kirk K. Calhoun's Career

NantHealth
NantHealth
Public$980.2M3402010Culver City, CA, US
Board Member· Board

Leadership at NantHealth

Patrick Soon-ShiongPatrick Soon-ShiongBoard Member
Michael D BlaszykMichael D BlaszykBoard Member

Similar to NantHealth

NavisHealthNavisHealthSanta Clara, CA, USHealthcare, IT Solutionsest. 2011NavisHealthSanta Clara, CA, US · est. 2011

NavisHealth: Silicon Valley-based digital health IT solutions provider, delivering innovative, secure, and interoperable solutions for US healthcare organizations.

Pre-Seed · $1M75
n1 Healthn1 HealthRichmond, VA, USHealthcare Plansest. 2010n1 HealthRichmond, VA, US · est. 2010

n1Health: An online platform offering personalized healthcare plans for patient-focused care.

Seed · $3.4M15
Clarify Health SolutionsClarify Health SolutionsSan Francisco, CA, USHealthcare Softwareest. 2015Clarify Health SolutionsSan Francisco, CA, US · est. 2015

Clarify Health Solutions: Providing data-driven healthcare software for optimized patient care in the US.

Series D · $328M261
Notable HealthNotable HealthSan Mateo, CA, USHealthcare Softwareest. 2017Notable HealthSan Mateo, CA, US · est. 2017

Notable Health: A health tech firm enhancing patient-physician interactions via intelligent automation.

Series B · $119.2M274
Ryerson Holding
Ryerson Holding
Public4.3k1842Chicago, IL, US
Board Member· Board

Leadership at Ryerson Holding

Nadir MohamedNadir MohamedBoard Member
Court CarruthersCourt CarruthersBoard Member
edward lehneredward lehnerCEO
Eddie LehnerEddie LehnerBoard Member
Leong FangLeong FangBoard Member
Stephen P. LarsonStephen P. LarsonBoard Member

Similar to Ryerson Holding

RelianceRelianceScottsdale, AZ, USMetalsest. 1939RelianceScottsdale, AZ, US · est. 1939

RSAC: North America's largest metals service center, providing processing services and distributing diverse metal products.

Public14.5k
Norilsk NickelNorilsk NickelMoscow, Moscow, RUest. 1993Norilsk NickelMoscow, Moscow, RU · est. 1993

Global producer of nickel, palladium, platinum, copper, and more. Serving customers worldwide.

Public73.7k
Rigidized MetalsRigidized MetalsBuffalo, NY, USMetal Productsest. 1940Rigidized MetalsBuffalo, NY, US · est. 1940

Rigidized® Metals, a global leader since 1940, manufactures deep-textured metals for various applications, known for their durability, aesthetic appeal, and cost-effectiveness.

Angel · $60k48
KennametalKennametalPittsburgh, PA, USIndustrial Materials, Toolingest. 1938KennametalPittsburgh, PA, US · est. 1938

Kennametal Inc: Global supplier of tooling systems, industrial materials, and wear-resistant parts.

Public8.7k
NeuroSigma
NeuroSigma
Public$18.4M72008Los Angeles, CA, US
Board Member· Board

Leadership at NeuroSigma

Alejandro CovalinAlejandro CovalinCo-Founder
Lodwrick CookLodwrick CookBoard Member
Leon EkchianLeon EkchianBoard Member

Similar to NeuroSigma

NeuroneticsNeuroneticsMalvern, PA, USHealthcare, Medical Devicesest. 2003NeuroneticsMalvern, PA, US · est. 2003

Neuronetics, Inc., a US-based company, develops therapies for chronic neuro health disorders.

Public · $373.4M194
NeuroPaceNeuroPaceMountain View, CA, USMedical Devicesest. 1997NeuroPaceMountain View, CA, US · est. 1997

NeuroPace, a California-based manufacturer, designs and markets implantable devices for treating neurological disorders.

Public · $307.3M167
NeuroBionicsNeuroBionicsSeattle, WA, USMedical DevicesNeuroBionicsSeattle, WA, US

Developing medical devices for neurological disorders.

Series A · $6M6
NeurotypeNeurotypeMinneapolis, MN, USMedical Deviceest. 2019NeurotypeMinneapolis, MN, US · est. 2019

NeuromarkR: A brain-focused medical device combating drug addiction via tailored psychotherapy and mindfulness strategies.

Seed · $1.2M5

Kirk K. Calhoun's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Kirk K. Calhoun

Paul A. RookePaul A. RookeBoard Member · PlexusChris SladeChris SladeCo-Founder · PlexisTodd KelseyTodd KelseyBoard Member · PlexusKenneth J. WidderKenneth J. WidderCEO · SydnexisKaran TakharKaran TakharBoard Member · Palleon PharmaceuticalsPeter T. KissingerPeter T. KissingerBoard Member · Inotiv